Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2026-02-20 @ 4:43 PM
Study NCT ID:
NCT03924869
Status:
TERMINATED
Last Update Posted:
2025-12-11
First Post:
2019-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-20
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-22
First Submit QC Date:
None
Study First Post Date:
2019-04-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-25
Results First Submit QC Date:
None
Results First Post Date:
2025-05-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24
Last Update Post Date:
2025-12-11
Last Update Post Date Type:
ESTIMATED